First clinical application of a prompt gamma based in vivo proton range verification system.

BACKGROUND AND PURPOSE To improve precision of particle therapy, in vivo range verification is highly desirable. Methods based on prompt gamma rays emitted during treatment seem promising but have not yet been applied clinically. Here we report on the worldwide first clinical application of prompt gamma imaging (PGI) based range verification. MATERIAL AND METHODS A prototype of a knife-edge shaped slit camera was used to measure the prompt gamma ray depth distribution during a proton treatment of a head and neck tumor for seven consecutive fractions. Inter-fractional variations of the prompt gamma profile were evaluated. For three fractions, in-room control CTs were acquired and evaluated for dose relevant changes. RESULTS The measurement of PGI profiles during proton treatment was successful. Based on the PGI information, inter-fractional global range variations were in the range of ±2 mm for all evaluated fractions. This is in agreement with the control CT evaluation showing negligible range variations of about 1.5mm. CONCLUSIONS For the first time, range verification based on prompt gamma imaging was applied for a clinical proton treatment. With the translation from basic physics experiments into clinical operation, the potential to improve the precision of particle therapy with this technique has increased considerably.

[1]  Joao Seco,et al.  Range verification of passively scattered proton beams using prompt gamma-ray detection , 2015, Physics in medicine and biology.

[2]  Chan Hyeong Kim,et al.  Prompt gamma measurements for locating the dose falloff region in the proton therapy , 2006 .

[3]  S. Helmbrecht,et al.  Measurement of prompt gamma profiles in inhomogeneous targets with a knife-edge slit camera during proton irradiation , 2015, Physics in medicine and biology.

[4]  Katia Parodi,et al.  In-beam PET measurements of β+ radioactivity induced by proton beams , 2002 .

[5]  Wolfgang Enghardt,et al.  First test of the prompt gamma ray timing method with heterogeneous targets at a clinical proton therapy facility , 2015, Physics in medicine and biology.

[6]  Joao Seco,et al.  Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Gregory C Sharp,et al.  In vivo proton beam range verification using spine MRI changes. , 2010, International journal of radiation oncology, biology, physics.

[8]  Joao Seco,et al.  Proton range verification through prompt gamma-ray spectroscopy , 2014, Physics in medicine and biology.

[9]  P. Busca,et al.  Prompt gamma imaging with a slit camera for real-time range control in proton therapy: Experimental validation up to 230 MeV with HICAM and development of a new prototype , 2012 .

[10]  G Janssens,et al.  Prompt gamma imaging of proton pencil beams at clinical dose rate , 2014, Physics in medicine and biology.

[11]  Todd Pawlicki,et al.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Radhe Mohan,et al.  Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration , 2012, Physics in medicine and biology.

[13]  Wolfgang Enghardt,et al.  Range assessment in particle therapy based on prompt γ-ray timing measurements , 2014, Physics in medicine and biology.

[14]  Antony Lomax,et al.  In vivo proton range verification: a review , 2013, Physics in medicine and biology.

[15]  E. Pedroni,et al.  Intensity modulated proton therapy: a clinical example. , 2001, Medical physics.

[16]  Johannes A Langendijk,et al.  Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  G Janssens,et al.  Towards clinical application: prompt gamma imaging of passively scattered proton fields with a knife-edge slit camera , 2016, Physics in medicine and biology.

[18]  S. Lorentini,et al.  Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Marco Durante,et al.  Dosimetric effects of residual uncertainties in carbon ion treatment of head chordoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  H. Paganetti.  Range uncertainties in proton therapy and the role of Monte Carlo simulations , 2012, Physics in medicine and biology.

[21]  Joe Y. Chang,et al.  Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Y. Lievens,et al.  Health economic controversy and cost-effectiveness of proton therapy. , 2013, Seminars in radiation oncology.

[23]  D. Thwaites,et al.  The on-going quest for treatment precision and conformality in radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  K Parodi,et al.  Dose quantification from in-beam positron emission tomography. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Harald Paganetti,et al.  Range verification of passively scattered proton beams based on prompt gamma time patterns , 2014, Physics in medicine and biology.